Sfoglia per AUTORE
AMOROSO V
Collezione AOU San Luigi di Orbassano
Items : 3
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial. in BMC cancer / BMC Cancer. 2023 Sep 26;23(1):908. doi: 10.1186/s12885-023-11287-2.
2023
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Corti F; Brizzi MP; Amoroso V; Giuffrida D; Panzuto F; Campana D; Prinzi N; Milione M; Cascella T; Spreafico C; Randon G; Oldani S; Leporati R; Scotto G; Pulice I; Stocchetti BL; Porcu L; Coppa J; Di Bartolomeo M; de Braud F; Pusceddu S;
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis. in Endocrine-related cancer / Endocr Relat Cancer. 2021 Jul 5;28(8):593-604. doi: 10.1530/ERC-21-0123.
2021
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Gurizzan C; Zamparini M; Volante M; Tovazzi V; Amoroso V; Consoli F; Petrelli F; Grisanti S; Bossi P; Berruti A;
Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2014 Dec 1;32(34):3883-91. doi: 10.1200/JCO.2014.55.2836. Epub 2014 Oct 27.
2014
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Berruti A; Amoroso V; Gallo F; Bertaglia V; Simoncini E; Pedersini R; Ferrari L; Bottini A; Bruzzi P; Sormani MP;